OM
INBX

Opaleye Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Opaleye Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-292,700
Closed -$5.25M – 53
2022
Q3 		$5.25M Sell
292,700
-297,300
-50% -$5.36M 2.17% 16
2022
Q2 		$6.7M Buy
+590,000
New +$8.68M 3.02% 12

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Opaleye Management's INBX Position: Q4 2022 in Review

Opaleye Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2022, closing a stake of 292,700 shares — an estimated $5.25M sold.

Opaleye Management first reported a position in INBX in Q2 2022 and held it in 2 quarters. The position peaked at $6.7M in Q2 2022. 116 funds tracked by Wall St. Rank hold INBX as of Q4 2022.

  • Opaleye Management reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Opaleye Management sold 292,700 Inhibrx, Inc. Common Stock shares in Q4 2022, an estimated $5.25M.
  • Opaleye Management first reported a position in Inhibrx, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Opaleye Management's Inhibrx, Inc. Common Stock position peaked at $6.7M in Q2 2022.
  • 116 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2022.

Based on Opaleye Management's 13F filing for Q4 2022, filed 10 Feb 2023.